More on TIL
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $8.55 |
|
|||
| Open | $8.55 | ||||
| 52 Wk High | $5.00 | ||||
| 52 Wk Low | $2.76 | ||||
| Day High | $9.00 | ||||
| Day Low | $8.35 | ||||
| P/E | 80.64 | ||||
| EPS | $0.11 | ||||
| Volume | 43,782 | ||||
- Form SCHEDULE 13G/A Instil Bio, Inc. Filed by: BML Investment Partners, L.P.
- H.C. Wainwright Downgrades Instil Bio Inc (TIL) to Neutral
- Instil Bio (TIL) Reiterated at Market Perform by Citizens
- Form 8-K Instil Bio, Inc. For: Jan 05
- Baird Downgrades Instil Bio Inc (TIL) to Neutral
- Instil Bio subsidiary discontinues AXN-2510 development, ends license deal
- Instil Bio’s Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco
- Instil Bio Inc. (TIL) Halted, News Pending
- Instil Bio (TIL) Shares are Fairly Valued Till Phase 2 Dose Results - Citizens
- Instil Bio Inc. (TIL) Misses Q3 EPS by 175c
Entities mentioned with TIL
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- Jefferies & Co | View Related Stories »
- Show More...
